Position in HLN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$227,428
-$91,630 QoQ
Shares Held
24,376
-23.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#268
of 639 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $2,780,936 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (8.2% of the industry book) .
All Filings in HLN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,428 | 24,376 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $319,058 | 31,874 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $267,369 | 26,446 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $210,337 | 23,449 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $305,209 | 29,432 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $284,734 | 27,671 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $197,840 | 20,738 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $202,046 | 19,097 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $163,927 | 19,846 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $157,166 | 18,512 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $151,934 | 18,461 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $169,490 | 20,347 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $169,301 | 20,203 | Shares | Sole | 2023-07-25 | |
| No filing history on record for this holder in this stock. | ||||||